Ph.D. Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences 1991; Post-Doctoral Johns Hopkins University 1994; Post-Doctoral Massachusetts Institute of Technology (MIT) 1997
R01 AI067111 (NIAID/NIH) 01/01/2006-12/31/2009
“HIV-1 glycopeptides as immunogens”
Role: Principal Investigator
R01 GM073717 (NIGMS/NIH) 09/01/2006-08/31/2009
“Enzymatic transglycosylation for N-glycopeptide synthesis”
Role: Principal Investigator
R01 GM080374 (NIGMS/NIH) 06/01/2007-05/31/2011
“Convergent chemoenzymatic synthesis of glycopeptides and glycoproteins”
Role: Principal Investigator
R01 AI046221 (NIAID/NIH) 04/01/2000-06/30/2004
“Rational design of antiviral compounds to the gp41 core”
Role: Co-PI (PI: Shibo Jiang - NYBC)
R21 DE015061 (NIDCR/NIH) 09/01/2002-08/31/2004
“Nonviral delivery of DNA vaccines to the buccal mucosa”
Role: Co-PI (PI: Maria Salvato - IHV)
R21 AI051235 (NIAID/NIH) 08/01/2003-04/31/2006
“Multivalent gp41 peptides as novel immunogens“
Role: Principal Investigator
R21 AI054354 (NIAID/NIH) 09/01/2003-08/31/2006
“Novel vaccine targeting the sugar coat of HIV-1“
Role: Principal Investigator
